NASDAQ: CTSOCytosorbents Corp Stock Ownership - Who owns Cytosorbents?
Insider buying vs selling
Have Cytosorbents Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alan D. Sobel | Director | 2026-09-15 | 1,900 | $6.12 | $11.63kBuy |
| Phillip P. Chan | CEO | 2026-09-15 | 3,774 | $6.00 | $22.64kBuy |
| Alan D. Sobel | Director | 2026-09-15 | 100 | $6.01 | $601.00Buy |
| Alan D. Sobel | Director | 2026-09-15 | 500 | $6.05 | $3.03kBuy |
| Vincent Capponi | COO;Pres | 2026-09-14 | 1,800 | $6.07 | $10.93kBuy |
| Vincent Capponi | COO;Pres | 2026-09-14 | 273 | $5.90 | $1.61kBuy |
| Phillip P. Chan | CEO | 2026-09-04 | 200,000 | $0.35 | $70.00kBuy |
| Peter J. Mariani | Chief Financial Officer | 2026-06-15 | 100,000 | $0.44 | $44.00kBuy |
| Phillip P. Chan | Chief Executive Officer | 2026-06-15 | 10,333 | $0.43 | $4.44kBuy |
| Phillip P. Chan | Chief Executive Officer | 2026-06-12 | 251,136 | $0.40 | $100.45kBuy |
CTSO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CTSO insiders and whales buy or sell their stock.
CTSO Shareholders
What type of owners hold Cytosorbents Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| David Lamadrid | 249.43% | 7,837,500 | $45.07M | Insider |
| Guillermina Vega Montiel | 158.94% | 4,993,984 | $28.72M | Insider |
| Margie Chassman | 152.60% | 4,795,000 | $27.57M | Insider |
| Robert Shipley | 94.61% | 2,972,819 | $17.09M | Insider |
| Njtc Investment Fund LP | 81.31% | 2,554,999 | $14.69M | Insider |
| Peter J. Mariani | 20.31% | 638,113 | $3.67M | Insider |
| Kathleen P. Bloch | 19.53% | 613,641 | $3.53M | Insider |
| Efthymios Deliargyris | 15.05% | 473,025 | $2.72M | Insider |
| Joseph Rubin | 9.75% | 306,363 | $1.76M | Insider |
| Alex Damico | 6.68% | 210,000 | $1.21M | Insider |
CTSO vs Medical Device Stocks
Cytosorbents Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.